| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 2.02e-05 | 26 | 41 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | sodium channel activity | 1.66e-04 | 52 | 41 | 3 | GO:0005272 | |
| GeneOntologyMolecularFunction | cytidine deaminase activity | 3.16e-04 | 13 | 41 | 2 | GO:0004126 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 3.69e-04 | 14 | 41 | 2 | GO:0140333 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 4.11e-04 | 171 | 41 | 4 | GO:0015081 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 4.71e-04 | 74 | 41 | 3 | GO:0005548 | |
| GeneOntologyMolecularFunction | flippase activity | 5.49e-04 | 17 | 41 | 2 | GO:0140327 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 6.16e-04 | 18 | 41 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.50e-03 | 28 | 41 | 2 | GO:0051959 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 1.50e-03 | 28 | 41 | 2 | GO:0140326 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 1.91e-03 | 120 | 41 | 3 | GO:0004222 | |
| GeneOntologyMolecularFunction | deaminase activity | 2.21e-03 | 34 | 41 | 2 | GO:0019239 | |
| GeneOntologyMolecularFunction | Wnt-protein binding | 2.21e-03 | 34 | 41 | 2 | GO:0017147 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines | 2.48e-03 | 36 | 41 | 2 | GO:0016814 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 2.62e-03 | 37 | 41 | 2 | GO:0045505 | |
| GeneOntologyMolecularFunction | carboxylic ester hydrolase activity | 4.08e-03 | 157 | 41 | 3 | GO:0052689 | |
| GeneOntologyMolecularFunction | transporter activity | 4.17e-03 | 1289 | 41 | 8 | GO:0005215 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 4.92e-03 | 51 | 41 | 2 | GO:0140303 | |
| GeneOntologyBiologicalProcess | clearance of foreign intracellular DNA | 5.20e-05 | 6 | 39 | 2 | GO:0044355 | |
| GeneOntologyBiologicalProcess | clearance of foreign intracellular nucleic acids | 5.20e-05 | 6 | 39 | 2 | GO:0099046 | |
| GeneOntologyBiologicalProcess | DNA cytosine deamination | 1.55e-04 | 10 | 39 | 2 | GO:0070383 | |
| GeneOntologyBiologicalProcess | cytidine to uridine editing | 2.27e-04 | 12 | 39 | 2 | GO:0016554 | |
| GeneOntologyBiologicalProcess | cytidine metabolic process | 3.12e-04 | 14 | 39 | 2 | GO:0046087 | |
| GeneOntologyBiologicalProcess | cytidine catabolic process | 3.12e-04 | 14 | 39 | 2 | GO:0006216 | |
| GeneOntologyBiologicalProcess | cytidine deamination | 3.12e-04 | 14 | 39 | 2 | GO:0009972 | |
| GeneOntologyBiologicalProcess | DNA deamination | 3.12e-04 | 14 | 39 | 2 | GO:0045006 | |
| GeneOntologyBiologicalProcess | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate | 4.11e-04 | 16 | 39 | 2 | GO:0045869 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside metabolic process | 4.11e-04 | 16 | 39 | 2 | GO:0046131 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside catabolic process | 4.11e-04 | 16 | 39 | 2 | GO:0046133 | |
| GeneOntologyBiologicalProcess | apical protein localization | 4.65e-04 | 17 | 39 | 2 | GO:0045176 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside catabolic process | 5.23e-04 | 18 | 39 | 2 | GO:0046135 | |
| GeneOntologyBiologicalProcess | regulation of single stranded viral RNA replication via double stranded DNA intermediate | 5.84e-04 | 19 | 39 | 2 | GO:0045091 | |
| GeneOntologyBiologicalProcess | base conversion or substitution editing | 5.84e-04 | 19 | 39 | 2 | GO:0016553 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 6.27e-04 | 208 | 39 | 4 | GO:0035725 | |
| GeneOntologyBiologicalProcess | single stranded viral RNA replication via double stranded DNA intermediate | 6.48e-04 | 20 | 39 | 2 | GO:0039692 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.67e-04 | 10 | 41 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 5.01e-04 | 17 | 41 | 2 | GO:0001518 | |
| GeneOntologyCellularComponent | sperm head-tail coupling apparatus | 5.63e-04 | 18 | 41 | 2 | GO:0120212 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.09e-03 | 25 | 41 | 2 | GO:0005858 | |
| GeneOntologyCellularComponent | sodium channel complex | 1.47e-03 | 29 | 41 | 2 | GO:0034706 | |
| Domain | Na_channel_asu | 2.09e-04 | 10 | 41 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 2.09e-04 | 10 | 41 | 2 | IPR010526 | |
| Domain | Allrgn_V5/Tpx1_CS | 2.09e-04 | 10 | 41 | 2 | IPR018244 | |
| Domain | Na_trans_assoc | 2.09e-04 | 10 | 41 | 2 | PF06512 | |
| Domain | CRISP_1 | 2.55e-04 | 11 | 41 | 2 | PS01009 | |
| Domain | CRISP_2 | 2.55e-04 | 11 | 41 | 2 | PS01010 | |
| Domain | Channel_four-helix_dom | 2.65e-04 | 57 | 41 | 3 | IPR027359 | |
| Domain | - | 2.65e-04 | 57 | 41 | 3 | 1.20.120.350 | |
| Domain | APOBEC_N | 3.06e-04 | 12 | 41 | 2 | PF08210 | |
| Domain | APOBEC_N | 3.06e-04 | 12 | 41 | 2 | IPR013158 | |
| Domain | ATPase_dyneun-rel_AAA | 4.21e-04 | 14 | 41 | 2 | IPR011704 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.21e-04 | 14 | 41 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 4.21e-04 | 14 | 41 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.21e-04 | 14 | 41 | 2 | IPR013602 | |
| Domain | DHC_N2 | 4.21e-04 | 14 | 41 | 2 | PF08393 | |
| Domain | MT | 4.21e-04 | 14 | 41 | 2 | PF12777 | |
| Domain | AAA_8 | 4.21e-04 | 14 | 41 | 2 | PF12780 | |
| Domain | APOBEC/CMP_deaminase_Zn-bd | 4.21e-04 | 14 | 41 | 2 | IPR016192 | |
| Domain | AAA_5 | 4.21e-04 | 14 | 41 | 2 | PF07728 | |
| Domain | DHC_fam | 4.85e-04 | 15 | 41 | 2 | IPR026983 | |
| Domain | - | 4.85e-04 | 15 | 41 | 2 | 3.40.33.10 | |
| Domain | Dynein_heavy_dom | 4.85e-04 | 15 | 41 | 2 | IPR004273 | |
| Domain | CAP | 4.85e-04 | 15 | 41 | 2 | PF00188 | |
| Domain | CAP_domain | 4.85e-04 | 15 | 41 | 2 | IPR014044 | |
| Domain | CYT_DCMP_DEAMINASES_2 | 4.85e-04 | 15 | 41 | 2 | PS51747 | |
| Domain | SCP | 4.85e-04 | 15 | 41 | 2 | SM00198 | |
| Domain | Allrgn_V5/Tpx1 | 4.85e-04 | 15 | 41 | 2 | IPR001283 | |
| Domain | Dynein_heavy | 4.85e-04 | 15 | 41 | 2 | PF03028 | |
| Domain | CYT_DCMP_DEAMINASES_1 | 6.26e-04 | 17 | 41 | 2 | PS00903 | |
| Domain | CMP_dCMP_Zn-bd | 6.26e-04 | 17 | 41 | 2 | IPR002125 | |
| Domain | Cytidine_deaminase-like | 6.26e-04 | 17 | 41 | 2 | IPR016193 | |
| Domain | Ion_trans_dom | 1.99e-03 | 114 | 41 | 3 | IPR005821 | |
| Domain | Ion_trans | 1.99e-03 | 114 | 41 | 3 | PF00520 | |
| Domain | AAA+_ATPase | 3.86e-03 | 144 | 41 | 3 | IPR003593 | |
| Domain | AAA | 3.86e-03 | 144 | 41 | 3 | SM00382 | |
| Domain | Rossmann-like_a/b/a_fold | 4.01e-03 | 43 | 41 | 2 | IPR014729 | |
| Domain | - | 4.01e-03 | 43 | 41 | 2 | 3.40.50.620 | |
| Domain | EGF_extracell | 7.68e-03 | 60 | 41 | 2 | IPR013111 | |
| Domain | EGF_2 | 7.68e-03 | 60 | 41 | 2 | PF07974 | |
| Pathway | REACTOME_MRNA_EDITING_C_TO_U_CONVERSION | 1.04e-04 | 7 | 32 | 2 | MM15412 | |
| Pathway | REACTOME_MRNA_EDITING | 1.78e-04 | 9 | 32 | 2 | MM15445 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 15937072 | ||
| Pubmed | Murine Leukemia Virus P50 Protein Counteracts APOBEC3 by Blocking Its Packaging. | 4.06e-06 | 3 | 41 | 2 | 32641479 | |
| Pubmed | APOBEC3 deletion increases the risk of breast cancer: a meta-analysis. | 4.06e-06 | 3 | 41 | 2 | 27602762 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 27841877 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 286744 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 22691411 | ||
| Pubmed | Studies on the restriction of murine leukemia viruses by mouse APOBEC3. | 4.06e-06 | 3 | 41 | 2 | 22666481 | |
| Pubmed | APOBEC3 deletion polymorphism is associated with epithelial ovarian cancer risk among Chinese women. | 4.06e-06 | 3 | 41 | 2 | 24577894 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 24725948 | ||
| Pubmed | APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism. | 4.06e-06 | 3 | 41 | 2 | 16648136 | |
| Pubmed | Fv1 restriction and retrovirus vaccine immunity in Apobec3-deficient 129P2 mice. | 4.06e-06 | 3 | 41 | 2 | 23533681 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 20702647 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 1541833 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 27356895 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 23315078 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 20980520 | ||
| Pubmed | Requirement for Fc effector mechanisms in the APOBEC3/Rfv3-dependent neutralizing antibody response. | 4.06e-06 | 3 | 41 | 2 | 25589647 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 284359 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 20617165 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 31801862 | ||
| Pubmed | Apobec-mediated retroviral hypermutation in vivo is dependent on mouse strain. | 4.06e-06 | 3 | 41 | 2 | 39208378 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 31943071 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 23671100 | ||
| Pubmed | Structural perspectives on HIV-1 Vif and APOBEC3 restriction factor interactions. | 4.06e-06 | 3 | 41 | 2 | 31518043 | |
| Pubmed | Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo. | 4.06e-06 | 3 | 41 | 2 | 20566830 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 17303427 | ||
| Pubmed | Chromosome mapping of Rfv3, a host resistance gene to Friend murine retrovirus. | 4.06e-06 | 3 | 41 | 2 | 7884913 | |
| Pubmed | N-linked glycosylation protects gammaretroviruses against deamination by APOBEC3 proteins. | 4.06e-06 | 3 | 41 | 2 | 25505062 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 31595054 | ||
| Pubmed | APOBEC3 signature mutations in chronic lymphocytic leukemia. | 4.06e-06 | 3 | 41 | 2 | 24840555 | |
| Pubmed | Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses. | 4.06e-06 | 3 | 41 | 2 | 17967065 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 20335265 | ||
| Pubmed | Deaminase-Dead Mouse APOBEC3 Is an In Vivo Retroviral Restriction Factor. | 4.06e-06 | 3 | 41 | 2 | 29593034 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 31830125 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 9765497 | ||
| Pubmed | Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response. | 4.06e-06 | 3 | 41 | 2 | 21998583 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 24453360 | ||
| Pubmed | Direct inhibition of human APOBEC3 deaminases by HIV-1 Vif independent of the proteolysis pathway. | 4.06e-06 | 3 | 41 | 2 | 38115583 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 23449789 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 2157836 | ||
| Pubmed | Distinctive High Expression of Antiretroviral APOBEC3 Protein in Mouse Germinal Center B Cells. | 4.06e-06 | 3 | 41 | 2 | 35458563 | |
| Pubmed | Natural resistance to HIV infection: The Vif-APOBEC interaction. | 4.06e-06 | 3 | 41 | 2 | 17067930 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 22275865 | ||
| Pubmed | APOBEC3-independent interferon-induced viral clearance in hepatitis B virus transgenic mice. | 4.06e-06 | 3 | 41 | 2 | 18434399 | |
| Pubmed | Induction of APOBEC3 in vivo causes increased restriction of retrovirus infection. | 4.06e-06 | 3 | 41 | 2 | 19153238 | |
| Pubmed | Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection. | 4.06e-06 | 3 | 41 | 2 | 18772436 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 293683 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 19150103 | ||
| Pubmed | Mouse APOBEC3 restricts friend leukemia virus infection and pathogenesis in vivo. | 4.06e-06 | 3 | 41 | 2 | 18786991 | |
| Pubmed | Initial sequencing and comparative analysis of the mouse genome. | 4.06e-06 | 3 | 41 | 2 | 12466850 | |
| Pubmed | Immunoglobulin somatic hypermutation by APOBEC3/Rfv3 during retroviral infection. | 8.12e-06 | 4 | 41 | 2 | 24821801 | |
| Pubmed | Small molecular compounds inhibit HIV-1 replication through specifically stabilizing APOBEC3G. | 8.12e-06 | 4 | 41 | 2 | 20363737 | |
| Pubmed | Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo. | 8.12e-06 | 4 | 41 | 2 | 18983852 | |
| Pubmed | Expression and subcellular localisation of AID and APOBEC3 in adenoid and palatine tonsils. | 8.12e-06 | 4 | 41 | 2 | 29343743 | |
| Pubmed | APOBEC3 regulates keratinocyte differentiation and expression of Notch3. | 8.12e-06 | 4 | 41 | 2 | 31400166 | |
| Pubmed | APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses. | 8.12e-06 | 4 | 41 | 2 | 15674295 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 21873525 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 23725696 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 21985787 | ||
| Pubmed | APOBEC3A functions as a restriction factor of human papillomavirus. | 8.12e-06 | 4 | 41 | 2 | 25355878 | |
| Pubmed | Human and murine APOBEC3s restrict replication of koala retrovirus by different mechanisms. | 8.12e-06 | 4 | 41 | 2 | 26253512 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 25501566 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 18702815 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 20538015 | ||
| Pubmed | Reversed functional organization of mouse and human APOBEC3 cytidine deaminase domains. | 8.12e-06 | 4 | 41 | 2 | 17020885 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 20375169 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 21147467 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 16055735 | ||
| Pubmed | The incorporation of APOBEC3 proteins into murine leukemia viruses. | 8.12e-06 | 4 | 41 | 2 | 18572219 | |
| Pubmed | The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance. | 8.12e-06 | 4 | 41 | 2 | 38049664 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 16378963 | ||
| Pubmed | Tetherin/BST-2 promotes dendritic cell activation and function during acute retrovirus infection. | 8.12e-06 | 4 | 41 | 2 | 26846717 | |
| Pubmed | Vaccinia virus replication is not affected by APOBEC3 family members. | 8.12e-06 | 4 | 41 | 2 | 17052331 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 28415995 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 9223268 | ||
| Pubmed | Species-specific restriction of apobec3-mediated hypermutation. | 8.12e-06 | 4 | 41 | 2 | 18032489 | |
| Pubmed | Multifaceted HIV-1 Vif interactions with human E3 ubiquitin ligase and APOBEC3s. | 8.12e-06 | 4 | 41 | 2 | 32893454 | |
| Pubmed | Reassessment of murine APOBEC1 as a retrovirus restriction factor in vivo. | 8.12e-06 | 4 | 41 | 2 | 25303118 | |
| Pubmed | APOBEC3 inhibits mouse mammary tumour virus replication in vivo. | 8.12e-06 | 4 | 41 | 2 | 17259974 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 11175280 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 23555255 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 36480186 | ||
| Pubmed | Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. | 8.12e-06 | 4 | 41 | 2 | 15269786 | |
| Pubmed | APOBEC3 inhibits DEAD-END function to regulate microRNA activity. | 1.35e-05 | 5 | 41 | 2 | 23890083 | |
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 21659520 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 18577210 | ||
| Pubmed | Different modes of retrovirus restriction by human APOBEC3A and APOBEC3G in vivo. | 1.35e-05 | 5 | 41 | 2 | 24851906 | |
| Pubmed | IFN-α and lipopolysaccharide upregulate APOBEC3 mRNA through different signaling pathways. | 1.35e-05 | 5 | 41 | 2 | 22972924 | |
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 18304004 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 17977970 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 18509452 | ||
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 32665269 | ||
| Pubmed | Retroelements versus APOBEC3 family members: No great escape from the magnificent seven. | 2.03e-05 | 6 | 41 | 2 | 22912627 | |
| Pubmed | APOBEC3 versus Retroviruses, Immunity versus Invasion: Clash of the Titans. | 2.03e-05 | 6 | 41 | 2 | 22720156 | |
| Pubmed | APOBEC3 proteins mediate the clearance of foreign DNA from human cells. | 2.84e-05 | 7 | 41 | 2 | 20062055 | |
| Pubmed | An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. | 2.84e-05 | 7 | 41 | 2 | 11863358 | |
| Pubmed | APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons. | 2.84e-05 | 7 | 41 | 2 | 16527742 | |
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 29871919 | ||
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 21835787 | ||
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 28082402 | ||
| Cytoband | 20q13.3 | 1.46e-04 | 20 | 41 | 2 | 20q13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q13 | 2.15e-04 | 330 | 41 | 4 | chr22q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p22 | 6.72e-03 | 137 | 41 | 2 | chr1p22 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 9.51e-05 | 9 | 30 | 2 | 1203 | |
| GeneFamily | Apolipoprotein B mRNA editing enzyme catalytic subunits | 1.74e-04 | 12 | 30 | 2 | 406 | |
| GeneFamily | Dyneins, axonemal | 3.56e-04 | 17 | 30 | 2 | 536 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-05 | 163 | 41 | 4 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-05 | 163 | 41 | 4 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.33e-05 | 182 | 41 | 4 | 03a5a02acd48f0eb210485348bfe0cd21f486215 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.94e-05 | 193 | 41 | 4 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.94e-05 | 193 | 41 | 4 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 3.12e-05 | 196 | 41 | 4 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 3.18e-05 | 197 | 41 | 4 | 6b6504c47c309bac4f790e2f372d454bbdea49e8 | |
| ToppCell | wk_20-22-Epithelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.18e-05 | 197 | 41 | 4 | 468071c1911cdf8e8806a78dbceb95379e28ae91 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Cilia-bearing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 3.37e-05 | 200 | 41 | 4 | 177f9ad8dd8635394c575a2b30140184df0bd51e | |
| ToppCell | VE-CD4-CD8_2|VE / Condition, Cell_class and T cell subcluster | 1.92e-04 | 122 | 41 | 3 | 6745035feaf807b6a6b9537ac9d5ee0e000196eb | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Agt_(Agt)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.59e-04 | 135 | 41 | 3 | 4cb399620aa9edc2ca59e4df76ab7011ceb58db9 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.59e-04 | 135 | 41 | 3 | 6bd2a0bfd8d20950f1b66810668682dc055a0ada | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.59e-04 | 135 | 41 | 3 | 7e3559ed0fef7916d1938b4e1a9fa4456a60e3d3 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Agt_(Agt)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.59e-04 | 135 | 41 | 3 | 97989546826bf3739e1b86a10832a457fd37c5d2 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Cdh13|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.65e-04 | 136 | 41 | 3 | 1f3000d5f105c87c80f8ae1dd2264bcd7f757a9c | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.76e-04 | 138 | 41 | 3 | 611fe0fb284e12678f9c47a0bdbfc367a93c52b3 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-MyoFB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.94e-04 | 141 | 41 | 3 | 7ae8ead02e5aeb4106c4a30c08a7a061da3a5d6a | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-04 | 148 | 41 | 3 | ba277c898678dd36f8dc1d681301c71901b89055 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-04 | 148 | 41 | 3 | b4632029ebd14969bda59a1bd1454eadb8efe563 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 3.60e-04 | 151 | 41 | 3 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid-granulocyte-granulocyte_l8|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.74e-04 | 153 | 41 | 3 | 338684d420b01e32918fa19048ccdda234942ce1 | |
| ToppCell | Severe-B_naive-5|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.74e-04 | 153 | 41 | 3 | 44572f87d403e314050ab935d2cd676c33d9c287 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD8-Trm_gut_CD8|bone_marrow / Manually curated celltypes from each tissue | 3.81e-04 | 154 | 41 | 3 | 93145a1bc5712ae664690b03a9e00ce1f92cfc7e | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-04 | 157 | 41 | 3 | 5d08ff0ba9d3df9cc30f13cab2d2b395ea6f3446 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-04 | 157 | 41 | 3 | ec433d2fe827abdb647be4176c231b7052482b6f | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-04 | 157 | 41 | 3 | ad9c9b7dfeee3ae46e7e593c51a0407df12195b4 | |
| ToppCell | Severe-B_naive-5|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.03e-04 | 157 | 41 | 3 | a57ee4a6febdff3ee3d1645836695e6e7c055cf8 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-04 | 158 | 41 | 3 | d43b335e6aa12d84a75b988fbd6127ff1f4af25c | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-04 | 158 | 41 | 3 | ab12b29ce51ca2fcac469cc932391217d97145f9 | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.18e-04 | 159 | 41 | 3 | baf843dc44b072504eb1d28de55b1ee67aeec32b | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.18e-04 | 159 | 41 | 3 | 9eb78202b9a4e8217f00e64d5142ed28c00abd04 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.18e-04 | 159 | 41 | 3 | 2233fee5dcdb6c7dee5b1bd8efbc07d86b339927 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-04 | 160 | 41 | 3 | f2cdee5a9e3b0eb125d6be7b5d239eb04333ae41 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.34e-04 | 161 | 41 | 3 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.34e-04 | 161 | 41 | 3 | a480107b1c7773f2081afca2657e0b7fc88a5645 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.34e-04 | 161 | 41 | 3 | 133b4fadb499e842c19f573f9cf09ce08c1d4813 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.34e-04 | 161 | 41 | 3 | cb177ca10d848d0e25399ab5ebfcde1071fb94c2 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.34e-04 | 161 | 41 | 3 | 9466b8658244116f8d21f2f88fb8c2d184b1bdf2 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-neutrophil-neutrophil|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.42e-04 | 162 | 41 | 3 | 4e7e565091bce227d794a36af2e5dfc4a791efad | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-neutrophil|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.42e-04 | 162 | 41 | 3 | ad974426039f4952c59d27167eac24dc6ce63f5e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.42e-04 | 162 | 41 | 3 | 285e6d553f485fd9f1075c4e1b940da251b5ea35 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.42e-04 | 162 | 41 | 3 | 96c6e94a10b124a1d25dcd705ec5aaa8609c1089 | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-04 | 164 | 41 | 3 | 950f87d9dacee45c9004a9bf894543de38f72ee5 | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-04 | 164 | 41 | 3 | bf0d3ad9016a0b8011a2385bb92f0a4f5edad1d6 | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-04 | 164 | 41 | 3 | c33910a6d87580902e9e7bd27afe6ea63b5eff8d | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-04 | 165 | 41 | 3 | c746bb22ef52d7f7fa6ee9c37ae6bbe0ccce718e | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.66e-04 | 165 | 41 | 3 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-04 | 165 | 41 | 3 | 4cdd80580d5638fd649280ba3893251c2f898f3f | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.66e-04 | 165 | 41 | 3 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | 343B-Lymphocytic-ILC|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.74e-04 | 166 | 41 | 3 | a54377c703efff42d2cc1a8fdb610facc58053dd | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L3-5_THEMIS_UBE2F|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.91e-04 | 168 | 41 | 3 | bfa1491e8d433933003778b274710d3a16d973cb | |
| ToppCell | facs-BAT-Fat-18m-Myeloid-granulocyte|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-04 | 169 | 41 | 3 | d3e6c75e5eda133fb6535cfe6c6a1026641f26ac | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.00e-04 | 169 | 41 | 3 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.17e-04 | 171 | 41 | 3 | d2938639e9a7c349e5a6ec61724222f9d127c89f | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-04 | 171 | 41 | 3 | 5447b78148f7bccb727e2fc108589b2af02a5d31 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-04 | 172 | 41 | 3 | a7eee0a30d2fe20c865a07b9004c6a821a72c0c4 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.26e-04 | 172 | 41 | 3 | c05af6e559f6af0fb15cefa03ffa1413e98a1a4a | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-04 | 172 | 41 | 3 | 0a9fe2cd28203970295a1288078c66eadac1c9ed | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Basophil|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.26e-04 | 172 | 41 | 3 | 953b05f776348cff784e79c93df65841939d880f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1-3_PAX6_NABP1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.26e-04 | 172 | 41 | 3 | 4ae0a3ba4660fc9292b7e9a3087a25a3349d8965 | |
| ToppCell | TCGA-Head_and_Esophagus-Solid_Tissue_Normal-Head_and_Neck-Head_and_Neck_normal_tissue-5|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 5.26e-04 | 172 | 41 | 3 | 6b8a8d3b97c10b9d092307eed3cacbd2745df185 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.35e-04 | 173 | 41 | 3 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.35e-04 | 173 | 41 | 3 | ee972d9cc68755926512fd3bbe1267098c67cd94 | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar-Ciliated_cell_of_lung_parenchyma|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.44e-04 | 174 | 41 | 3 | f41d05a3703d7092bd3c4a97c15ae13069aaa4ad | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.44e-04 | 174 | 41 | 3 | 6c36d607c48267a75ab4da6fb2fe3f931d1b3b52 | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.53e-04 | 175 | 41 | 3 | c01a15b2084da4a18f8ff3623f44eb9dfe499f10 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.53e-04 | 175 | 41 | 3 | f6e1d7297a4dbb38e1ab4f738d91f0e62abaee69 | |
| ToppCell | Ciliated_cells-A-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 5.62e-04 | 176 | 41 | 3 | 1c364155f46b9a7c995bdc2cc2333c437cd90f5b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L6_LHX6_GLP1R|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.72e-04 | 177 | 41 | 3 | 2b675840b7d2bb536c2c600936733bd9e97e7120 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.72e-04 | 177 | 41 | 3 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L6_LHX6_GLP1R|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.72e-04 | 177 | 41 | 3 | 5e0fca9bd5e5ffe6d39f5bcd81f36512f3b0cb1b | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.72e-04 | 177 | 41 | 3 | aef050784abbba45c4ab4e8328339c8739c5c453 | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.72e-04 | 177 | 41 | 3 | 3cfde67b93f3986312f5e74e42504214d966e7dc | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.72e-04 | 177 | 41 | 3 | 12a52a12a87a31e501ced611f46a90d172ca7e35 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.81e-04 | 178 | 41 | 3 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.91e-04 | 179 | 41 | 3 | b35a7f8115c997c390201da01d7cb10b10769aec | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.00e-04 | 180 | 41 | 3 | b7513b9816a9cb9f3caaddb2a9fed0be1c7f9805 | |
| ToppCell | Ciliated_cells-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 6.00e-04 | 180 | 41 | 3 | bdea5ec6b60fc8c7cce4d71db5da74ac8675e211 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.00e-04 | 180 | 41 | 3 | f96c5be4705e3d338c0393d2885ac8d5beccd6fd | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 6.10e-04 | 181 | 41 | 3 | 88f6f56f5f58b479d5db91b32c45934c045f88ea | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.10e-04 | 181 | 41 | 3 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.20e-04 | 182 | 41 | 3 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 6.20e-04 | 182 | 41 | 3 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.20e-04 | 182 | 41 | 3 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-04 | 182 | 41 | 3 | b8be66a867ea1bbae0820b26dbd55b68611f5ad5 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.20e-04 | 182 | 41 | 3 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Deuterosomal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.20e-04 | 182 | 41 | 3 | 000eca5baa6eb2335a1e6d76a13fff5382b0e150 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-04 | 182 | 41 | 3 | f96095b81188b52db8fcfca4837129cfcd9bd7b7 | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-04 | 182 | 41 | 3 | cb488f9a9b200e2557335ccf22535cd247512cdc | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.30e-04 | 183 | 41 | 3 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.30e-04 | 183 | 41 | 3 | c5b10571599dc26476170b54b53f09c23e6b3117 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.40e-04 | 184 | 41 | 3 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.40e-04 | 184 | 41 | 3 | a8c6028d745aaa6ee7842259238694cb50ce0526 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.40e-04 | 184 | 41 | 3 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 6.40e-04 | 184 | 41 | 3 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.40e-04 | 184 | 41 | 3 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.40e-04 | 184 | 41 | 3 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.40e-04 | 184 | 41 | 3 | 9cc5c588f7c6631b3fb8a522214a09ca32947e72 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.40e-04 | 184 | 41 | 3 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 | |
| ToppCell | Control-immature_Neutrophil-|Control / Disease condition and Cell class | 6.40e-04 | 184 | 41 | 3 | c4e8ba82a6aa76c46f05a71d5f1c7926555318cf | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 7.61e-05 | 10 | 39 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 7.61e-05 | 10 | 39 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | Congenital ichthyosis of skin | 9.29e-05 | 11 | 39 | 2 | cv:C0020758 | |
| Disease | Congenital Nonbullous Ichthyosiform Erythroderma | 9.29e-05 | 11 | 39 | 2 | C0079154 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.11e-04 | 12 | 39 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | heart rate | 2.20e-04 | 225 | 39 | 4 | EFO_0004326 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KFSEWGNNAFFYYFE | 436 | P06276 | |
| EEFAYCWENFVYNEG | 151 | Q9UH17 | |
| SFNWYEDNNYKAFLG | 336 | P78363 | |
| QFLWDFYQGSIFEDA | 891 | Q9NYQ6 | |
| ALFFAYYWDDNFDPA | 11 | Q7Z5J1 | |
| YYWDDNFDPASLQGA | 16 | Q7Z5J1 | |
| FNGYSAQTAYEDWFI | 971 | O43520 | |
| LHFDGYSDCYDFWVN | 296 | Q96JM7 | |
| ALFADNAYWLENYAN | 86 | Q5VXI9 | |
| YYDNQDFPATNWDDK | 141 | Q7Z429 | |
| EYWNDVFSDFLNEYE | 76 | O75648 | |
| FDYDWYNVSDQADLV | 251 | Q96N19 | |
| DLYENDNAAWDYDNG | 221 | Q5FYB0 | |
| DERYFFQGNQYWRYD | 406 | Q8N119 | |
| YQFFDESKNWYESQA | 111 | P26718 | |
| DLSDYFNYGFNEDTW | 171 | Q6UN15 | |
| FNYGFNEDTWKAYCE | 176 | Q6UN15 | |
| FHFYWLDAYEDQYNQ | 341 | P09884 | |
| EFAYCWENFVYSEGQ | 151 | Q8IUX4 | |
| YQDFGGFYDRNKLFW | 2186 | Q9C0G6 | |
| QAIQSWFDEYNDFDF | 111 | P54108 | |
| ANWDLFYYRFGQDHA | 756 | O75165 | |
| DDWENFAYSLGYEPN | 2271 | Q99698 | |
| EHWAEDTFFGYQYLN | 256 | O75342 | |
| YYFAWTLADAVNNAA | 296 | Q6ZNC8 | |
| AWYNETQFYDFDSLS | 116 | Q6UWM5 | |
| GWNVYYDFNESDFQV | 4041 | Q8IVF4 | |
| DADTYGNFNNLRFWY | 2526 | Q6ZTR5 | |
| YQFYWGVEEQEAFEC | 841 | A6NKG5 | |
| FDWDAYISDEGNFYF | 336 | P35499 | |
| FYQKEHWNYFGADEN | 496 | O43166 | |
| ADWNNCYYTFDGKYE | 206 | Q9NSE4 | |
| GNYSGYDDAWDQDRF | 31 | O15160 | |
| DWLYAGDYFERNFSD | 461 | Q9H1P3 | |
| EAGNYWFDIFNDYAA | 451 | Q9NP91 | |
| RWGVFDEYNEDQPFY | 161 | Q14CN2 | |
| YADYLFNAIAGNWER | 146 | A6NFA1 | |
| VAGAEYWDNNDHRDY | 261 | O95685 | |
| SNENGWTTFYEYDSF | 1686 | Q6N022 | |
| WQAAGQAEYFYEFLS | 91 | Q9Y5W5 | |
| DYNYTNFDNFGWSFL | 336 | Q9UI33 | |
| FEQLEYWANNFDDFA | 626 | Q8NHX9 | |
| DTLYFFGDNNFTEWA | 131 | Q96S16 |